Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,947 | -23,967 | N/A | N/A | N/A |
| Depreciation Amortization | 668 | 619 | N/A | N/A | N/A |
| Other Working Capital | -2,630 | 3,300 | N/A | N/A | N/A |
| Other Operating Activity | 3,713 | 1,150 | 0 | 0 | 0 |
| Operating Cash Flow | $-31,196 | $-18,898 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -917 | -96 | N/A | N/A | N/A |
| Investing Cash Flow | $-917 | $-96 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 258,461 | 19 | N/A | N/A | N/A |
| Other Financing Activity | 150,045 | 8,591 | 0 | 0 | 0 |
| Financing Cash Flow | $408,506 | $8,610 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 10,526 | 20,910 | N/A | N/A | N/A |
| End Cash Position | 386,919 | 10,526 | N/A | N/A | N/A |
| Net Cash Flow | $376,393 | $-10,384 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,196 | -18,898 | N/A | N/A | N/A |
| Capital Expenditure | -917 | -96 | N/A | N/A | N/A |
| Free Cash Flow | -32,113 | -18,994 | 0 | 0 | 0 |